Infliximab-induced discoid lupus erythematosus.

Abstract:

:Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy is currently used in the treatment of various inflammatory diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Infliximab is a chimeric monoclonal antibody that binds to transmembrane-bound and soluble TNF-α. Previously, a discoid lupus erythematosus-like eruption linked to its use was rarely reported in patients with rheumatoid arthritis. We present a case of rheumatoid arthritis which developed such an eruption after treatment with infliximab. The lesions resolved after the discontinuation of infliximab. In the present case, the clinical, serological and immunohistochemical features of our patient are discussed with the literature.

journal_name

Lupus

journal_title

Lupus

authors

Cemil BC,Atas H,Canpolat F,Akca Y,Sasmaz R

doi

10.1177/0961203313479423

subject

Has Abstract

pub_date

2013-04-01 00:00:00

pages

515-8

issue

5

eissn

0961-2033

issn

1477-0962

pii

22/5/515

journal_volume

22

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Photoprotective habits in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can involve multiple organ systems. Exposure to ultraviolet radiation (UVR) can exacerbate pre-existing SLE, and can even induce systemic manifestations. This study aimed to investigate the photoprotective habits of children with SLE and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320930098

    authors: Janthongsri T,Wisuthsarewong W,Nitiyarom R

    更新日期:2020-07-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00

  • Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.

    abstract::Azathioprine-induced aplastic anemia and fatal myelosuppression is a rare occurrence in patients with systemic lupus erythematosus (SLE). We report a case of a 53-year-old female with a normal thiopurine S-methyltransferase (TPMT) level who developed aplastic anemia within 4 weeks of azathioprine initiation, resulting...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313504636

    authors: Yeter KC,Afkhami M,Brynes RK,Quismorio FP Jr

    更新日期:2013-12-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • Affinity purified human antiphospholipid antibodies bind normal term placenta.

    abstract::Antiphospholipid antibodies (aPL) are associated with an increased incidence of fetal loss, but the pathophysiology remains unclear. One mechanism may involve the binding of aPL directly to the placenta where they may initiate placental thrombosis and infarction. We have developed an immunofluorescent technique to det...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840756

    authors: Donohoe S,Kingdom JC,Mackie IJ

    更新日期:1999-01-01 00:00:00

  • Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases.

    abstract::Q fever has extremely polymorphic features, and has been reported to be associated with positivity of several autoimmune antibodies. We report two cases of atypical Q fever with a clinical presentation highly suggestive of an inflammatory systemic disease with positivity of autoimmune antibodies, mimicking systemic lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317747721

    authors: Durupt S,Puget M,Lega JC,Durieu I,Reynaud Q

    更新日期:2017-01-01 00:00:00

  • Primigravida is associated with flare in women with systemic lupus erythematosus.

    abstract::The objective of this study was to identify risk factors associated with flare during pregnancy in women with systemic lupus erythematosus (SLE). We performed a retrospective analysis of pregnant women with SLE in a referral hospital. Flare was considered according to predetermined definitions. We analyzed 15 clinical...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314552116

    authors: Saavedra MA,Sánchez A,Morales S,Navarro-Zarza JE,Ángeles U,Jara LJ

    更新日期:2015-02-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • Protein S deficiency revealed by skin necrosis in a patient with lupus.

    abstract::Protein S deficiency is rare in systemic lupus erythematosus (SLE) and is generally associated with the presence of antiphospholipid (APL) antibodies. Lack of protein S can cause skin necrosis, but when it does it is generally in response to warfarin exposure. In this article, we describe the case of a patient who had...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319843345

    authors: Plana-Pla A,Bielsa Marsol I,Ferrandiz Foraster C

    更新日期:2019-06-01 00:00:00

  • The illness experience of youth with lupus/mixed connective tissue disease: a mixed methods analysis of patient and parent perspectives.

    abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646460

    authors: Knight A,Vickery M,Fiks AG,Barg FK

    更新日期:2016-08-01 00:00:00

  • Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study.

    abstract::The objective of this study was to determine whether there are differences in the prevalence, clinical and laboratory manifestations, and morbidity and mortality of systemic lupus erythematosus (SLE) between Aborigines and Caucasians in Central Australia. The medical records of all patients diagnosed with SLE upto Dec...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301678646191

    authors: Segasothy M,Phillips PA

    更新日期:2001-01-01 00:00:00

  • Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.

    abstract::Therapeutic agents currently in use to treat systemic lupus erythematosus (SLE) are predominantly immunosuppressive agents with limited specificities. Multiple groups, including ours, have illustrated that inducing tolerance in SLE animal models ameliorates disease symptoms and increases survival. We examined if oral ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311398509

    authors: Skaggs BJ,Lourenço EV,Hahn BH

    更新日期:2011-08-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00

  • Induced abortions in women with systemic lupus erythematosus.

    abstract:OBJECTIVES:To determine the rates of induced abortions in women with systemic lupus erythematosus (SLE) compared to women from the general population and assess disease-related predictors of induced abortion in women with SLE. METHODS:We identified women with SLE (15-45 years) and determined the number of induced abor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320979741

    authors: Venne K,Scott S,Bernatsky S,Vinet E

    更新日期:2020-12-15 00:00:00

  • Decreased mRNA levels coding for poly(ADP-ribose) polymerase in lymphocytes of patients with SLE.

    abstract::Poly(ADP-ribose) metabolism is altered in patients with SLE. In order to localize the defect, the levels of poly(ADP-ribose) polymerase-specific mRNA were measured from dot blots of total RNA from peripheral blood lymphocytes. In this preliminary study, eleven patients with SLE and two with antiphospholipid syndrome w...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300210

    authors: Lee JS,Haug BL,Sibley JT

    更新日期:1994-04-01 00:00:00

  • Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study.

    abstract::The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600305

    authors: Hanly JG

    更新日期:1997-01-01 00:00:00

  • Innate immunity and atherogenesis.

    abstract::Atherosclerosis is recognized as the pathological basis of cardiovascular disease (CVD) and recent advances in basic science have shown that it should be considered as a chronic inflammatory process. Both elements of the innate and the adaptive immunity appear to be actively involved in atherogenesis. In fact, the pot...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2213oa

    authors: Rattazzi M,Faggin E,Bertipaglia B,Pauletto P

    更新日期:2005-01-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00

  • A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland.

    abstract::Seventeen families, in which the diagnosis of SLE could be verified in two relatives, were included in the study. The diagnosis was made according to the revised 1982 ARA criteria. We compared the 34 cases of familial SLE in these 17 families with 34 non-familial SLE controls matched for age, sex, ethnicity and durati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500408

    authors: Gourley IS,Cunnane G,Bresnihan B,FitzGerald O,Bell AL

    更新日期:1996-08-01 00:00:00

  • Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus.

    abstract::Leukopenia and anaemia are observed in about a fifth of all patients with systemic lupus erythematosus (SLE) and may be due either to the destruction of blood cells or their decreased production. The former may be humoral or cell-mediated or result from apoptosis of peripheral blood cells. Several observations suggest...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu423oa

    authors: Tiefenthaler M,Bacher N,Linert H,Mühlmann O,Hofer S,Sepp N,Amberger A,Geisen F,Obermoser G,Konwalinka G

    更新日期:2003-01-01 00:00:00

  • Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system.

    abstract::The effect of beta 2glycoprotein I (beta 2GPI) and human monoclonal anticardiolipin antibody (aCL) on the protein S/C4b-binding protein (C4BP) system was evaluated. The binding of C4BP to protein S was assessed by ELISA in the presence of beta 2GPI with/without human monoclonal aCL. beta 2GPI downregulated the binding...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600403

    authors: Atsumi T,Khamashta MA,Ames PR,Ichikawa K,Koike T,Hughes GR

    更新日期:1997-01-01 00:00:00

  • Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

    abstract::In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) group published a new set of classification criteria for systemic lupus erythematosus (SLE). Studies applying these criteria to real-life scenarios have found either equal or greater sensitivity and equal or lower specificity to the 1997 ACR class...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657434

    authors: Ungprasert P,Sagar V,Crowson CS,Amin S,Makol A,Ernste FC,Osborn TG,Moder KG,Niewold TB,Maradit-Kremers H,Ramsey-Goldman R,Chowdhary VR

    更新日期:2017-03-01 00:00:00

  • Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.

    abstract::Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of e...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309358187

    authors: Ortega LM,Schultz DR,Lenz O,Pardo V,Contreras GN

    更新日期:2010-04-01 00:00:00

  • Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox.

    abstract::The outcome, quality of life and prognosis of lupus patients can be enhanced with close follow up and coordination between the individual's primary care physician and rheumatologist. Rheumatologists usually do not act as primary care physicians and leave health care maintenance to practitioners who need to be reminded...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086267

    authors: Wallace DJ

    更新日期:2008-02-01 00:00:00

  • Association between TYK2 polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis.

    abstract:OBJECTIVE:This study aimed to explore whether TYK2 polymorphisms are associated with susceptibility to autoimmune rheumatic diseases. METHODS:We conducted a meta-analysis on the association between TYK2 polymorphisms and autoimmune rheumatic diseases. RESULTS:Twelve studies with a total of 16,335 patients and 30,065 ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316638933

    authors: Lee YH,Bae SC

    更新日期:2016-10-01 00:00:00

  • Vitamin D insufficiency in a large female SLE cohort.

    abstract::The objective of this study was to determine the vitamin D status and its relationship with disease and therapy features and with bone mineral density in women with systemic lupus erythematosus. Non-pregnant systemic lupus erythematosus women with dual-energy X-ray absorptiometry and vitamin D measurements performed b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345775

    authors: Toloza SM,Cole DE,Gladman DD,Ibañez D,Urowitz MB

    更新日期:2010-01-01 00:00:00

  • Emergence of panniculitis and haemophagocytic syndrome in a patient with chronic systemic lupus erythematosus.

    abstract::Panniculitis rarely occurs in the course of systemic lupus erythematosus (SLE). When it occurs, it is thought to be mainly lupus erythematosus panniculitis (LEP). Here we describe a 32-year old Japanese woman with chronic SLE, who simultaneously presented facial lymphocytic lobular panniculitis and pancytopenia due to...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307077560

    authors: Deji N,Sugimoto T,Fujimoto T,Aoyama M,Takeda N,Sakaguchi M,Uzu T,Kashiwagi A

    更新日期:2007-01-01 00:00:00

  • The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.

    abstract::Antiphospholipid syndrome (APS), as a primary disease or a secondary syndrome in systemic lupus erythematosus (SLE), is characterized by the presence of antiphospholipid antibodies (aPL) and a clinical event. It is likely that both genetic and environmental factors lead to the development of aPL and progression to dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314548248

    authors: Salem D,Subang R,Laplante P,Levine JS,Rauch J

    更新日期:2014-10-01 00:00:00

  • Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.

    abstract::Anti-phospholipid antibodies are common in patients in the Hopkins' Lupus Cohort: 47% have anti-cardiolipin, 32.5% anti-beta(2)-glycoprotein I and 26% lupus anticoagulant (by dRVVT confirmatory testing). Systemic lupus erythematosus patients with the lupus anticoagulant at baseline have a 50% chance of a deep venous t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360541

    authors: Petri M

    更新日期:2010-04-01 00:00:00

  • Role of HLA in congenital heart block: susceptibility alleles in children.

    abstract::Congenital heart block (CHB) is a syndrome of uncertain pathogenesis leading to cardiac conduction disturbances in the foetus and newborns. It has been proposed that maternal antibodies transmit immunological injury in the developing foetal heart, thus causing irreversible damage of the atrioventricular node, leading ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847407

    authors: Sirén MK,Julkunen H,Kaaja R,Ekblad H,Koskimies S

    更新日期:1999-01-01 00:00:00